McDonough Brian 4

Accession 0000899243-22-034824

CIK 0001596946other

View on SEC.gov Company Profile

Filed

Nov 1, 8:00 PM ET

Accepted

Nov 2, 8:00 PM ET

Size

26.1 KB

Accession

0000899243-22-034824

Insider Transaction Report

Form 4

Period: 2022-10-31

Quotient LtdQTNT

McDonough Brian

Director

Transactions

Award
Restricted Stock Units
2022-10-31+70,000→ 70,000 total
→ Ordinary Shares (70,000 underlying)
Award
Ordinary Share Option (Right to Buy)
2022-10-31+40,000→ 40,000 total
Exercise: $0.13Exp: 2032-10-31→ Ordinary Shares (40,000 underlying)
Exercise/Conversion
Ordinary Shares
2022-10-31+6,917→ 83,144 total
Exercise/Conversion
Restricted Stock Units
2022-10-31−6,917→ 0 total
→ Ordinary Shares (6,917 underlying)

Holdings

Ordinary Shares Option (Right to buy)
Exercise: $4.55Exp: 2030-10-31→ Ordinary Shares (13,611 underlying)
13,611
Ordinary Shares
(indirect: By Trust)
53,040
Ordinary Shares Option (Right to buy)
Exercise: $7.78Exp: 2029-10-31→ Ordinary Shares (8,158 underlying)
8,158
Ordinary Shares Option (Right to buy)
Exercise: $2.53Exp: 2031-10-31→ Ordinary Shares (24,040 underlying)
24,040
Ordinary Shares Option (Right to buy)
Exercise: $9.95Exp: 2024-10-31→ Ordinary Shares (5,025 underlying)
5,025
Ordinary Shares Option (Right to buy)
Exercise: $11.62Exp: 2025-10-31→ Ordinary Shares (4,303 underlying)
4,303
Ordinary Shares Option (Right to buy)
Exercise: $5.21Exp: 2027-10-31→ Ordinary Shares (9,597 underlying)
9,597
Ordinary Shares Option (Right to buy)
Exercise: $8.00Exp: 2024-04-29→ Ordinary Shares (10,000 underlying)
10,000
Options to purchase ordinary shares
From: 2014-11-14Exp: 2022-08-30→ Ordinary Shares (40,029 underlying)
40,029
Ordinary Shares Option (Right to buy)
Exercise: $5.73Exp: 2026-10-31→ Ordinary Shares (8,726 underlying)
8,726
Ordinary Shares Option (Right to buy)
Exercise: $6.41Exp: 2028-10-31→ Ordinary Shares (6,240 underlying)
6,240

Footnotes (15)

[F1]All 10,000 options have vested and remain exercisable.
[F10]All 8,158 options have vested and remain exercisable.
[F11]All 13,611 options have vested and remain exercisable.
[F12]On October 31, 2021, the Reporting Person was granted 27,668 restricted stock units, of which 27,668 have vested and have converted into ordinary shares.
[F13]All 24,040 options have vested and remain exercisable.
[F14]On October 31, 2022, the Reporting Person was granted 70,000 restricted stock units, vesting in four equal installments on January 31, 2023, April 30, 2023, July 31, 2023 and October 31, 2023.
[F15]The options vest and become exercisable on October 31, 2023.
[F2]The exercise price will be paid in pounds sterling, at GBP 0.91 per share.
[F3]All 5,025 options have vested and remain exercisable.
[F4]All 4,303 options have vested and remain exercisable.
[F5]All 8,726 options have vested and remain exercisable.
[F6]Restricted Stock Units convert into ordinary shares on a one-for-one basis.
[F7]All 9,597 options have vested and remain exercisable.
[F8]All 6,240 options have vested and remain exercisable.
[F9]The Reporting Person and his spouse are Co-Trustees of their successors in trust, of the McDonough-McGuire Joint Revocable Trust, dated May 14, 2013. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these ordinary shares in this report shall not be deemed an admission of beneficial ownership of all of the reported ordinary shares for purposes of Section 16 or for any other purpose.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Quotient Ltd

CIK 0001596946

→

Entity typeother

Related Parties

filerCIK 0001605065

Filing Metadata

Form type: 4
Filed: Nov 1, 8:00 PM ET
Accepted: Nov 2, 8:00 PM ET
Size: 26.1 KB

View on SEC.gov